Schedule 13G ownership disclosure

Cullinan Therapeutics Inc

Security class unavailable · CUSIP: 230031106

Event date: 2024-04-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.7100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-24-000557
Form type
SC 13G
Filer
Cullinan Therapeutics, Inc.
CIK
CIK 1789972
Filed
Apr 24, 2024
Reporting period
Apr 18, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub